163 related articles for article (PubMed ID: 16840358)
1. Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells.
Noser JA; Towers GJ; Sakuma R; Dumont JM; Collins MK; Ikeda Y
J Virol; 2006 Aug; 80(15):7769-74. PubMed ID: 16840358
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z; Ylinen LM; Towers GJ
J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
[TBL] [Abstract][Full Text] [Related]
3. Efficient transduction of human hematopoietic repopulating cells with a chimeric HIV1-based vector including SIV capsid.
Uchida N; Hsieh MM; Washington KN; Tisdale JF
Exp Hematol; 2013 Sep; 41(9):779-788.e1. PubMed ID: 23665451
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
Kahl CA; Cannon PM; Oldenburg J; Tarantal AF; Kohn DB
Gene Ther; 2008 Aug; 15(15):1079-89. PubMed ID: 18385767
[TBL] [Abstract][Full Text] [Related]
5. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle.
Daelemans D; Dumont JM; Rosenwirth B; De Clercq E; Pannecouque C
Antiviral Res; 2010 Feb; 85(2):418-21. PubMed ID: 19857522
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
Ptak RG; Gallay PA; Jochmans D; Halestrap AP; Ruegg UT; Pallansch LA; Bobardt MD; de Béthune MP; Neyts J; De Clercq E; Dumont JM; Scalfaro P; Besseghir K; Wenger RM; Rosenwirth B
Antimicrob Agents Chemother; 2008 Apr; 52(4):1302-17. PubMed ID: 18212100
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.
Stremlau M; Song B; Javanbakht H; Perron M; Sodroski J
Virology; 2006 Jul; 351(1):112-20. PubMed ID: 16643975
[TBL] [Abstract][Full Text] [Related]
8. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum.
Croyle MA; Callahan SM; Auricchio A; Schumer G; Linse KD; Wilson JM; Brunner LJ; Kobinger GP
J Virol; 2004 Jan; 78(2):912-21. PubMed ID: 14694122
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.
Khan M; Jin L; Huang MB; Miles L; Bond VC; Powell MD
J Virol; 2004 Feb; 78(4):1843-50. PubMed ID: 14747548
[TBL] [Abstract][Full Text] [Related]
10. Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.
Geis FK; Galla M; Hoffmann D; Kuehle J; Zychlinski D; Maetzig T; Schott JW; Schwarzer A; Goffinet C; Goff SP; Schambach A
Retrovirology; 2017 May; 14(1):34. PubMed ID: 28569216
[TBL] [Abstract][Full Text] [Related]
11. Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells.
Uchida N; Washington KN; Hayakawa J; Hsieh MM; Bonifacino AC; Krouse AE; Metzger ME; Donahue RE; Tisdale JF
J Virol; 2009 Oct; 83(19):9854-62. PubMed ID: 19625395
[TBL] [Abstract][Full Text] [Related]
12. Chimeric human immunodeficiency virus type 1 virions that contain the simian immunodeficiency virus nef gene are cyclosporin A resistant.
Khan M; Jin L; Miles L; Bond VC; Powell MD
J Virol; 2005 Mar; 79(5):3211-6. PubMed ID: 15709044
[TBL] [Abstract][Full Text] [Related]
13. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.
Dorfman T; Göttlinger HG
J Virol; 1996 Sep; 70(9):5751-7. PubMed ID: 8709190
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus vectors using human and simian immunodeficiency virus elements.
White SM; Renda M; Nam NY; Klimatcheva E; Zhu Y; Fisk J; Halterman M; Rimel BJ; Federoff H; Pandya S; Rosenblatt JD; Planelles V
J Virol; 1999 Apr; 73(4):2832-40. PubMed ID: 10074131
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses.
Braaten D; Franke EK; Luban J
J Virol; 1996 Jul; 70(7):4220-7. PubMed ID: 8676442
[TBL] [Abstract][Full Text] [Related]
16. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
Sokolskaja E; Sayah DM; Luban J
J Virol; 2004 Dec; 78(23):12800-8. PubMed ID: 15542632
[TBL] [Abstract][Full Text] [Related]
17. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
18. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
[TBL] [Abstract][Full Text] [Related]
19. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.
Li Y; Li X; Stremlau M; Lee M; Sodroski J
J Virol; 2006 Jul; 80(14):6738-44. PubMed ID: 16809279
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.
Braun SE; Lu XV; Wong FE; Connole M; Qiu G; Chen Z; Slepushkina T; Slepushkin V; Humeau LM; Dropulic B; Johnson RP
Hum Gene Ther; 2007 Jul; 18(7):653-64. PubMed ID: 17600461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
